Please login to the form below

Troxyca ER

This page shows the latest Troxyca ER news and features for those working in and with pharma, biotech and healthcare.

FDA panel backs Pfizer and Teva abuse-resistant painkillers

In the case of Troxyca ER, the inclusion of opioid blocker naltrexone is designed to achieve the same end result. ... The company secured rights to Troxyca ER (also known as ALO-02) when it acquired King Pharmaceuticals in 2010 for $3.6bn.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Account Director: Competitive Salary Offered

Senior Account Director development role to Business Director, H...: Excellent package

Account Director – Healthcare Marketing – Berks: Salary TBC

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Medical Writer: Salary TBC

Senior Account Manager, Rare Diseases – Medical Communications, ...: Excellent package

Account Director, Medical Education: Salary TBC

Senior Medical Writer: Salary TBC

Client Services Director – Medical Education Agency – North West...: Salary TBC

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Associate Director: £75, 000-90, 000

Business Director: Competitive Salary Offered

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Senior Account Manager: Competitive Salary Offered

Account Director – Health Policy – Global Agency: Salary TBC

Home-based Senior Project Manager – Independent Med Ed: Salary TBC

Account Manager / Account Director: Competative

Global Business Development Director – Health Education: excellent commission

Engagement Expert, Healthcare Brand Communications, London: Excellent package

Senior Director – Healthcare PR – Global Agency: Salary TBC

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Account Manager / Senior Account Manager: 35, 000-40, 000

Account Director, Healthcare Marketing Agency: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Fendix

Latest intelligence

The UK’s new five-year pricing agreement: Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape: Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch: ...